Royalty Pharma plc (RPRX)
USD 31.01
(-2.45%)
USD 31.01
(-2.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.38 Billion USD | -2.57% |
| 2022 | 16.81 Billion USD | -4.01% |
| 2021 | 17.51 Billion USD | -16.97% |
| 2020 | 21.09 Billion USD | 69.46% |
| 2019 | 12.44 Billion USD | 9.5% |
| 2018 | 11.37 Billion USD | -0.03% |
| 2017 | 11.37 Billion USD | 8.51% |
| 2016 | 10.48 Billion USD | -3.09% |
| 2015 | 10.81 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 17.65 Billion USD | 9.46% |
| 2024 Q1 | 16.13 Billion USD | -1.53% |
| 2023 Q4 | 16.38 Billion USD | 3.32% |
| 2023 Q2 | 17.12 Billion USD | 0.28% |
| 2023 Q3 | 15.85 Billion USD | -7.39% |
| 2023 Q1 | 17.07 Billion USD | 1.55% |
| 2023 FY | 16.38 Billion USD | -2.57% |
| 2022 Q2 | 17.74 Billion USD | 2.08% |
| 2022 FY | 16.81 Billion USD | -4.01% |
| 2022 Q4 | 16.81 Billion USD | -4.86% |
| 2022 Q1 | 17.37 Billion USD | -0.78% |
| 2022 Q3 | 17.67 Billion USD | -0.38% |
| 2021 Q2 | 16.51 Billion USD | 3.78% |
| 2021 FY | 17.51 Billion USD | -16.97% |
| 2021 Q4 | 17.51 Billion USD | -1.22% |
| 2021 Q3 | 17.73 Billion USD | 7.37% |
| 2021 Q1 | 15.91 Billion USD | -24.57% |
| 2020 Q1 | 13.37 Billion USD | 7.4% |
| 2020 FY | 21.09 Billion USD | 69.46% |
| 2020 Q4 | 21.09 Billion USD | -1.13% |
| 2020 Q3 | 21.33 Billion USD | 36.03% |
| 2020 Q2 | 15.68 Billion USD | 17.3% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 12.44 Billion USD | 0.0% |
| 2019 FY | 12.44 Billion USD | 9.5% |
| 2018 FY | 11.37 Billion USD | -0.03% |
| 2017 FY | 11.37 Billion USD | 8.51% |
| 2016 FY | 10.48 Billion USD | -3.09% |
| 2015 FY | 10.81 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -1000.861% |
| Alkermes plc | 2.13 Billion USD | -666.861% |
| Agenus Inc. | 313.91 Million USD | -5118.596% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -327.738% |
| Aptorum Group Limited | 20.64 Million USD | -79269.083% |
| Ardelyx, Inc. | 297.57 Million USD | -5405.043% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -2039.874% |
| Bicycle Therapeutics plc | 595.34 Million USD | -2651.661% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -22127.146% |
| ChromaDex Corporation | 54.96 Million USD | -29704.692% |
| Chimerix, Inc. | 212.77 Million USD | -7599.179% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -57842.923% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -3614.975% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -634.754% |
| Precision BioSciences, Inc. | 159.78 Million USD | -10152.69% |
| Dyadic International, Inc. | 8.21 Million USD | -199211.116% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -51512.637% |
| Fortress Biotech, Inc. | 167.52 Million USD | -9678.692% |
| Lantern Pharma Inc. | 43.64 Million USD | -37432.064% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -10053.809% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -112826.516% |
| Incyte Corporation | 6.78 Billion USD | -141.545% |
| IO Biotech, Inc. | 150.71 Million USD | -10769.207% |
| Jaguar Health, Inc. | 50.76 Million USD | -32171.243% |
| Novavax, Inc. | 1.85 Billion USD | -782.956% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -4206.401% |
| Opthea Limited | 188.79 Million USD | -8577.232% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -1866.458% |
| ContextLogic Inc. | 423 Million USD | -3772.778% |
| MiMedx Group, Inc. | 239.04 Million USD | -6752.983% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -9329.706% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -316781.982% |
| NextCure, Inc. | 129.41 Million USD | -12558.093% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -30266.002% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -44501.952% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -50616.235% |
| Vaxcyte, Inc. | 1.4 Billion USD | -1063.552% |
| PDS Biotechnology Corporation | 59.39 Million USD | -27483.48% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -2457.478% |
| Pharming Group N.V. | 462.85 Million USD | -3439.313% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -42252.252% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -2506.272% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -86468.021% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -86468.021% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -9809.177% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -36073.407% |
| Acelyrin, Inc. | 742.69 Million USD | -2105.745% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -248617.738% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -255746.494% |
| Summit Therapeutics Inc. | 202.94 Million USD | -7971.905% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -21926.314% |
| Senti Biosciences, Inc. | 119.48 Million USD | -13610.498% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -7074.261% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -9641.013% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -198155.488% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -343063.954% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -3391.503% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -13148.244% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -5858.142% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -3364.565% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -162016.289% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -7537.013% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -1446856.744% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -3858.48% |
| Immix Biopharma, Inc. | 19.92 Million USD | -82116.911% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -4327.228% |
| MEI Pharma, Inc. | 41.37 Million USD | -39493.598% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -50451.907% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -4706.909% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -13874.708% |
| Fortress Biotech, Inc. | 167.52 Million USD | -9678.692% |
| Precigen, Inc. | 151.04 Million USD | -10745.819% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -48056.42% |
| AlloVir, Inc. | 190.79 Million USD | -8486.056% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -4251.656% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -3136.132% |
| ImmuCell Corporation | 43.8 Million USD | -37294.569% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -2422.94% |
| Onconetix, Inc. | 88.82 Million USD | -18343.575% |
| PureTech Health plc | 693.97 Million USD | -2260.589% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -16670.078% |
| Elevation Oncology, Inc. | 89.09 Million USD | -18287.773% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -264038.197% |
| Seer, Inc. | 436.26 Million USD | -3654.989% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -19976.536% |
| Innoviva, Inc. | 1.24 Billion USD | -1217.391% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -12270.85% |
| ESSA Pharma Inc. | 149.12 Million USD | -10885.526% |
| GlycoMimetics, Inc. | 45.31 Million USD | -36049.879% |
| GT Biopharma, Inc. | 14.1 Million USD | -116009.228% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -5220.631% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -6677.678% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -3371.415% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -32213.255% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -17105.658% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -2593655.898% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -2792.577% |
| Aptose Biosciences Inc. | 12.92 Million USD | -126669.551% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -73978.143% |
| Soligenix, Inc. | 9.79 Million USD | -167107.369% |
| Century Therapeutics, Inc. | 360.69 Million USD | -4441.796% |
| Kura Oncology, Inc. | 448.93 Million USD | -3549.047% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -5919.442% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -94620.156% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -14670.224% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -7885.265% |
| Autolus Therapeutics plc | 375.38 Million USD | -4264.06% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -6410.138% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -4512.215% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -33242.528% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -2377.841% |
| GRI Bio, Inc. | 2.95 Million USD | -554089.817% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -154369.608% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -9507.279% |
| IGM Biosciences, Inc. | 423.41 Million USD | -3769.019% |
| INmune Bio, Inc. | 57 Million USD | -28639.585% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -7262.431% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -19415.852% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -62625.198% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -237897.776% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -21676.847% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -11024.592% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -9798.16% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -2501.929% |
| Verastem, Inc. | 149.71 Million USD | -10841.805% |
| Abeona Therapeutics Inc. | 64 Million USD | -25495.842% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -3098.618% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -10506.092% |
| Histogen Inc. | 19.07 Million USD | -85790.269% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -72225.497% |
| Surrozen, Inc. | 46.08 Million USD | -35450.892% |
| Organovo Holdings, Inc. | 6.34 Million USD | -257922.539% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -380111.088% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -11274.17% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -138705.719% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -21664.695% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -192192.174% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -4413.292% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -90435.49% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -3715.038% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -129793.869% |
| Apollomics, Inc. | 55.38 Million USD | -29477.069% |
| Amarin Corporation plc | 831.68 Million USD | -1869.721% |
| Mesoblast Limited | 669.15 Million USD | -2348.147% |
| Turnstone Biologics Corp. | 112.81 Million USD | -14420.987% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -2745.262% |
| Synaptogenix, Inc. | 31.11 Million USD | -52551.624% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -134353.8% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -2889.051% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -278870.076% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -222929.222% |
| Exelixis, Inc. | 2.94 Billion USD | -456.759% |
| Better Therapeutics, Inc. | 22.94 Million USD | -71302.393% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -4393.854% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -1976.991% |
| NLS Pharmaceutics AG | 1.84 Million USD | -887016.175% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -205221.5% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -111379.081% |
| Gritstone bio, Inc. | 177.76 Million USD | -9115.246% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -17075.352% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -91612.033% |
| Avid Bioservices, Inc. | 336.55 Million USD | -4767.482% |
| Insmed Incorporated | 1.32 Billion USD | -1131.869% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -170041.92% |
| MediWound Ltd. | 66.45 Million USD | -24549.56% |
| OmniAb, Inc. | 401.98 Million USD | -3975.239% |
| Alector, Inc. | 621.82 Million USD | -2534.471% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -4468.28% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -304508.609% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -28796.231% |
| Zai Lab Limited | 1.03 Billion USD | -1480.81% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -3323.913% |
| Aura Biosciences, Inc. | 255.07 Million USD | -6322.366% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -2084.162% |
| Immunic, Inc. | 54.29 Million USD | -30069.71% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -6053.409% |
| Veracyte, Inc. | 1.13 Billion USD | -1339.756% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -138461.728% |
| FibroGen, Inc. | 423.52 Million USD | -3767.941% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -466220.837% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -345756.389% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -301620.552% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | -43.784% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -185951.687% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -3065.856% |
| TG Therapeutics, Inc. | 329.58 Million USD | -4870.418% |
| Galecto, Inc. | 38.22 Million USD | -42754.137% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -57027.392% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -275.972% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -6859.037% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -65844.171% |
| XBiotech Inc. | 227.24 Million USD | -7108.957% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -17075.352% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -11387.974% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -5629.603% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -12711.433% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -4188.454% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -998.706% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -4390.122% |
| Vaxxinity, Inc. | 44.35 Million USD | -36835.159% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -3068.882% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -87930.306% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -5270.218% |
| NexImmune, Inc. | 8.59 Million USD | -190520.761% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -152784.373% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -95547.09% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 50.478% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -73854.919% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -4176120.412% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -9351.304% |
| Ainos, Inc. | 31.84 Million USD | -51347.622% |
| Pluri Inc. | 39.52 Million USD | -41344.711% |
| Prothena Corporation plc | 696.38 Million USD | -2252.423% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -5696.505% |
| Celularity Inc. | 143.88 Million USD | -11285.061% |
| Rallybio Corporation | 115.62 Million USD | -14068.7% |
| Cue Biopharma, Inc. | 61.53 Million USD | -26524.169% |
| MeiraGTx Holdings plc | 458.16 Million USD | -3475.512% |
| Omeros Corporation | 378.26 Million USD | -4230.741% |
| Humacyte, Inc. | 128.22 Million USD | -12676.063% |
| Immunocore Holdings plc | 597 Million USD | -2644.024% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -52306.83% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -23804.642% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -1461.291% |
| CalciMedica, Inc. | 12.18 Million USD | -134342.766% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -6358.447% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -9485.187% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -5166.883% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -2797.909% |
| Pulmatrix, Inc. | 33.95 Million USD | -48141.507% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -60247.2% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -11530.047% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -1159.196% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -12483.127% |
| Cytokinetics, Incorporated | 824.31 Million USD | -1887.327% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -77454.566% |
| Nutriband Inc. | 7.51 Million USD | -217826.239% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -20648.602% |
| Vor Biopharma Inc. | 209.82 Million USD | -7707.276% |
| Roivant Sciences Ltd. | 7.22 Billion USD | -126.817% |
| Evogene Ltd. | 51.1 Million USD | -31957.789% |
| ProKidney Corp. | 420.55 Million USD | -3795.321% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -29775.898% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -171973.242% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -2898.252% |
| CorMedix Inc. | 82.05 Million USD | -19863.27% |
| BioLineRx Ltd. | 63.92 Million USD | -25526.673% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -3969.348% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -57991.67% |
| Atai Life Sciences N.V. | 293.47 Million USD | -5481.969% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -9942.24% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -12756.779% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -2814.78% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -16837.573% |
| MediciNova, Inc. | 66.26 Million USD | -24619.868% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -18526.746% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -367011.408% |
| GeoVax Labs, Inc. | 9.28 Million USD | -176367.355% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -2684.911% |
| Biomea Fusion, Inc. | 199.92 Million USD | -8093.916% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -760.762% |
| Mereo BioPharma Group plc | 66.49 Million USD | -24534.733% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -3277.033% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -2572.93% |
| Absci Corporation | 234.48 Million USD | -6886.46% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -223848.749% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -4719.737% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -9823.463% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -3012.515% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -5799.267% |
| Allakos Inc. | 243.61 Million USD | -6624.622% |
| Imunon, Inc. | 21.91 Million USD | -74641.306% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -6257.094% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -2535.785% |
| BioAtla, Inc. | 119.65 Million USD | -13590.561% |
| NLS Pharmaceutics AG | 1.84 Million USD | -887016.175% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -508653.137% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -2448.368% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -16975.99% |
| XOMA Corporation | 234.3 Million USD | -6891.797% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -7304.728% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -12917.586% |
| aTyr Pharma, Inc. | 122.06 Million USD | -13320.377% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -10544.27% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -2723.138% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -3240.344% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -14729.365% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -107977.105% |
| Akari Therapeutics, Plc | 4.35 Million USD | -376061.906% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -96052.672% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -845.141% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -531090.835% |
| UroGen Pharma Ltd. | 178.31 Million USD | -9087.235% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -3380.051% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -2947787.136% |
| Orgenesis Inc. | 14.55 Million USD | -112474.567% |
| Entera Bio Ltd. | 11.76 Million USD | -139142.252% |
| GH Research PLC | 226.3 Million USD | -7138.997% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -29851.825% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -15148.009% |
| Xencor, Inc. | 952.69 Million USD | -1619.533% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -210361.626% |
| Replimune Group, Inc. | 487.72 Million USD | -3258.85% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -202869.525% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -2426.348% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -531090.835% |
| Portage Biotech Inc. | 7.77 Million USD | -210490.706% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -367011.408% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -5815.2% |
| OncoCyte Corporation | 74.89 Million USD | -21773.967% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -805598.616% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -282997.661% |
| Purple Biotech Ltd. | 44.3 Million USD | -36877.678% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -47904.017% |
| scPharmaceuticals Inc. | 94.47 Million USD | -17239.145% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -90683.536% |
| HilleVax, Inc. | 344.43 Million USD | -4656.165% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -515701.354% |
| Tharimmune, Inc. | 10.94 Million USD | -149555.243% |
| Genprex, Inc. | 10.67 Million USD | -153423.357% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -3201.495% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -16919.751% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -675161.789% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -393180.111% |
| OKYO Pharma Limited | 1.54 Million USD | -1062784.165% |
| Savara Inc. | 177.56 Million USD | -9125.885% |
| Curis, Inc. | 77.28 Million USD | -21097.499% |
| Daré Bioscience, Inc. | 21.28 Million USD | -76874.37% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -25517.135% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -202495.239% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -84468.948% |
| BeiGene, Ltd. | 5.8 Billion USD | -182.189% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -134519.533% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -684.349% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -4476.562% |
| Erasca, Inc. | 395.29 Million USD | -4044.188% |
| bluebird bio, Inc. | 619.16 Million USD | -2545.814% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -378814.014% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -139.445% |
| DBV Technologies S.A. | 182.98 Million USD | -8852.516% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -378814.014% |
| Moderna, Inc. | 18.42 Billion USD | 11.094% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -89826.173% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -141293.501% |
| Molecular Templates, Inc. | 35.38 Million USD | -46198.649% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -11748.155% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -1976.509% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -5293.113% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -15659.963% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -3418.235% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -5126.521% |
| MacroGenics, Inc. | 306.82 Million USD | -5239.238% |
| RenovoRx, Inc. | 1.46 Million USD | -1117352.319% |
| Adicet Bio, Inc. | 207.29 Million USD | -7802.675% |
| Prime Medicine, Inc. | 193.85 Million USD | -8350.744% |
| Aditxt, Inc. | 44.57 Million USD | -36648.465% |
| Adagene Inc. | 115.72 Million USD | -14055.375% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -367685.269% |
| Quantum-Si incorporated | 298.25 Million USD | -5392.658% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -1001.338% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -212399.541% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -4563.461% |
| SciSparc Ltd. | 11.18 Million USD | -146401.976% |
| Vericel Corporation | 353.65 Million USD | -4532.13% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -134038.831% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -28690.29% |
| Generation Bio Co. | 374.75 Million USD | -4271.315% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -6332.681% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -10231.186% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -4698.925% |
| Invivyd, Inc. | 229.18 Million USD | -7047.997% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -1841.024% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -134516.204% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -8881.77% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -80108.828% |
| 2seventy bio, Inc. | 565.42 Million USD | -2797.258% |
| ADMA Biologics, Inc. | 329.18 Million USD | -4876.533% |
| Clene Inc. | 52.34 Million USD | -31198.315% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -27791.442% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -12511.707% |
| GeoVax Labs, Inc. | 9.28 Million USD | -176367.355% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -2406.024% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -15710.896% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -12464.118% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -16692.935% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -22974.005% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -6653.926% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -735.77% |
| Evaxion Biotech A/S | 12.88 Million USD | -127003.23% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -6399.187% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -2076.446% |
| Trevena, Inc. | 40.6 Million USD | -40244.418% |
| Surrozen, Inc. | 46.08 Million USD | -35450.892% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -7153.196% |
| Cingulate Inc. | 3.49 Million USD | -469100.953% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -98413.747% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -24838.12% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -140100.034% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -6000.862% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -2087.292% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -12912.623% |
| Clearmind Medicine Inc. | 4.32 Million USD | -378724.639% |
| Kronos Bio, Inc. | 213.27 Million USD | -7580.949% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -10152.498% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -191263.127% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -4345.67% |
| Statera Biopharma, Inc. | 21.16 Million USD | -77283.537% |
| ImmunityBio, Inc. | 504.45 Million USD | -3147.455% |
| Korro Bio, Inc. | 221.66 Million USD | -7290.431% |
| Kineta, Inc. | 10.28 Million USD | -159241.027% |
| BioVie Inc. | 25.2 Million USD | -64885.825% |
| Codexis, Inc. | 136.56 Million USD | -11895.995% |
| Celularity Inc. | 143.88 Million USD | -11285.061% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -2478.386% |
| Celcuity Inc. | 191.21 Million USD | -8467.045% |
| Virax Biolabs Group Limited | 5.48 Million USD | -298622.531% |
| Cibus, Inc. | 544.41 Million USD | -2909.096% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -12912.416% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -79640.318% |
| IN8bio, Inc. | 33.7 Million USD | -48497.855% |
| Kodiak Sciences Inc. | 479.37 Million USD | -3317.357% |
| Annexon, Inc. | 297.67 Million USD | -5403.286% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -9368.731% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -11816.76% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -77934.826% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -447.875% |
| Eyenovia, Inc. | 28.77 Million USD | -56822.194% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -7006.23% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -226669.809% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -26788.112% |
| Arcellx, Inc. | 825.13 Million USD | -1885.361% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -19966.699% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -3443.746% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -53174.312% |
| Moolec Science SA | 24.05 Million USD | -68012.154% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -5182.338% |
| Geron Corporation | 394.07 Million USD | -4057.028% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -16006.431% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -2653.4% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -234099.918% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -136105.376% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -7146.683% |
| Humacyte, Inc. | 128.22 Million USD | -12676.063% |
| Structure Therapeutics Inc. | 482.01 Million USD | -3298.604% |
| 89bio, Inc. | 596.26 Million USD | -2647.393% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -6396.816% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -885405.459% |
| Genelux Corporation | 27.89 Million USD | -58631.047% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -18223.603% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -7040.27% |
| Notable Labs, Ltd. | 19.54 Million USD | -83733.228% |
| Liquidia Corporation | 120.43 Million USD | -13502.686% |
| Mustang Bio, Inc. | 17.74 Million USD | -92233.734% |
| Immunovant, Inc. | 666.71 Million USD | -2357.111% |
| Quantum-Si incorporated | 298.25 Million USD | -5392.658% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -11244.694% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -30147.14% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -9231.942% |
| Acasti Pharma Inc. | 73.3 Million USD | -22249.046% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -359760.277% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -62625.198% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -1597.957% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -315547.588% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -71810.149% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -31645.928% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -8966.224% |
| PepGen Inc. | 143.05 Million USD | -11351.676% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -42765.35% |
| United Therapeutics Corporation | 7.16 Billion USD | -128.573% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -85288.851% |
| Solid Biosciences Inc. | 164.93 Million USD | -9832.066% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -278870.076% |
| Immuneering Corporation | 102.58 Million USD | -15869.123% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -380111.088% |
| Silo Pharma, Inc. | 7.74 Million USD | -211384.028% |
| Belite Bio, Inc | 94.64 Million USD | -17209.282% |
| XOMA Corporation | 234.3 Million USD | -6891.797% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -6925.169% |
| Bionomics Limited | 27.64 Million USD | -59149.144% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -3981.138% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -15154.825% |
| uniQure N.V. | 831.68 Million USD | -1869.709% |
| Cassava Sciences, Inc. | 151.66 Million USD | -10701.482% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -367685.269% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -5881.288% |
| Forte Biosciences, Inc. | 38.98 Million USD | -41926.298% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -402094.758% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -44378.431% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -226669.809% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -466220.837% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -138482.616% |
| Altimmune, Inc. | 210.64 Million USD | -7677.18% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -2005.961% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -15154.825% |
| Compugen Ltd. | 121.33 Million USD | -13401.451% |
| Peak Bio, Inc. | 2.59 Million USD | -630841.163% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -9406.259% |
| Benitec Biopharma Inc. | 52.21 Million USD | -31276.845% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -4691.991% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -47010.836% |
| Zura Bio Limited | 100.84 Million USD | -16144.906% |
| PolyPid Ltd. | 15.37 Million USD | -106469.418% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -13633.255% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -47010.836% |
| Instil Bio, Inc. | 325.63 Million USD | -4930.817% |
| argenx SE | 4.54 Billion USD | -260.638% |
| Immunome, Inc. | 148.54 Million USD | -10928.579% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -10342.614% |
| Verona Pharma plc | 308.12 Million USD | -5216.642% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -18738.592% |
| Shattuck Labs, Inc. | 159.56 Million USD | -10166.633% |
| CervoMed Inc. | 9.97 Million USD | -164169.907% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -8592.666% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -143751.87% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -9031.212% |
| Moolec Science SA | 24.05 Million USD | -68012.154% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -267687.569% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -9372.321% |
| AnaptysBio, Inc. | 452.38 Million USD | -3521.187% |
| Design Therapeutics, Inc. | 289.64 Million USD | -5555.877% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -22394.818% |
| NeurAxis, Inc. | 509.49 Thousand USD | -3215192.504% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -302259.745% |
| Lumos Pharma, Inc. | 40.63 Million USD | -40211.657% |
| Achilles Therapeutics plc | 161.45 Million USD | -10046.325% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -18738.592% |
| 180 Life Sciences Corp. | 5.25 Million USD | -311373.063% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -23160.49% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -191263.127% |
| Nutriband Inc. | 7.51 Million USD | -217826.239% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -6332.176% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -8119.653% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -21395.107% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -28185.536% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -3011.226% |
| Palisade Bio, Inc. | 14.05 Million USD | -116480.209% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -7689.938% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -1022.264% |
| Neurogene Inc. | 222.57 Million USD | -7260.215% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -2433.455% |
| AEON Biopharma, Inc. | 6.84 Million USD | -239225.8% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -3516.015% |
| Sesen Bio, Inc. | 189.17 Million USD | -8559.674% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -5925.686% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -119372.041% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -1999.293% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -6035.663% |
| Athira Pharma, Inc. | 160.24 Million USD | -10123.003% |
| Vaccinex, Inc. | 3.63 Million USD | -451066.373% |
| HCW Biologics Inc. | 28.51 Million USD | -57352.642% |
| XOMA Corporation | 234.3 Million USD | -6891.797% |
| Nektar Therapeutics | 398.03 Million USD | -4015.702% |
| Arvinas, Inc. | 1.3 Billion USD | -1155.699% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -96052.672% |
| Merus N.V. | 458.49 Million USD | -3472.97% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -7915.938% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -8990.726% |
| Rezolute, Inc. | 132.73 Million USD | -12241.586% |
| Clene Inc. | 52.34 Million USD | -31198.315% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -109669.398% |
| BeyondSpring Inc. | 24.8 Million USD | -65934.549% |
| Synlogic, Inc. | 75.55 Million USD | -21583.456% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -138003.617% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -174845.013% |
| Peak Bio, Inc. | 2.59 Million USD | -630841.163% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -9269.999% |
| Krystal Biotech, Inc. | 818.35 Million USD | -1901.803% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -6713.337% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -2157.112% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -457855.106% |
| MannKind Corporation | 475.19 Million USD | -3347.374% |
| Ikena Oncology, Inc. | 192.09 Million USD | -8428.128% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -122390.287% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -13956.969% |
| Gossamer Bio, Inc. | 311.91 Million USD | -5152.007% |
| CohBar, Inc. | 16.36 Million USD | -99998.89% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -46488.32% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -223848.749% |
| Legend Biotech Corporation | 1.84 Billion USD | -786.172% |
| Mural Oncology plc | 301.74 Million USD | -5329.038% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -52380.702% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -288292.307% |
| Disc Medicine, Inc. | 367.99 Million USD | -4351.638% |
| Champions Oncology, Inc. | 26.13 Million USD | -62588.853% |
| REGENXBIO Inc. | 573.97 Million USD | -2754.13% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -604823.811% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -10510.969% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -135560.987% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -4717.696% |
| Vaxart, Inc. | 91.83 Million USD | -17739.324% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -27246.893% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -10944.423% |
| Cellectis S.A. | 334.27 Million USD | -4800.784% |
| Longeveron Inc. | 12.17 Million USD | -134420.044% |
| Repare Therapeutics Inc. | 253.9 Million USD | -6352.062% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -401.806% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -8056.383% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -684.349% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -1008013.908% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -5798.884% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -9944.177% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -11707.25% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -64087.176% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 27.929% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -1319.673% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -134038.831% |
| Veru Inc. | 50.59 Million USD | -32277.807% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -35862.178% |
| Cingulate Inc. | 3.49 Million USD | -469100.953% |
| Passage Bio, Inc. | 150.54 Million USD | -10781.697% |
| Context Therapeutics Inc. | 16.06 Million USD | -101886.685% |
| Exicure, Inc. | 11.58 Million USD | -141366.762% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -4256.319% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -10034.65% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -93660.594% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -4823.245% |
| Nuvalent, Inc. | 732.38 Million USD | -2136.784% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -109521.014% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -18192.707% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -115338.313% |
| OmniAb, Inc. | 401.98 Million USD | -3975.239% |
| Anew Medical, Inc. | 19.45 Million USD | -84099.684% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -61194.286% |
| Lipocine Inc. | 23 Million USD | -71122.12% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -11617.476% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -5261.167% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -19415.852% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -13378.568% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -206350.548% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -1756.77% |
| Ocugen, Inc. | 64.54 Million USD | -25279.725% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -13053.781% |
| Q32 Bio Inc. | 306.11 Million USD | -5251.465% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -389202.543% |
| Alumis Inc. Common Stock | 89.61 Million USD | -18180.868% |
| Equillium, Inc. | 50.53 Million USD | -32320.049% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -21685.825% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -39590.943% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -963055.017% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -62567.27% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -25321.472% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -439431.911% |
| Dominari Holdings Inc. | 57.55 Million USD | -28361.467% |
| Edesa Biotech, Inc. | 8.89 Million USD | -184163.732% |
| vTv Therapeutics Inc. | 11.01 Million USD | -148582.619% |
| Bio-Techne Corporation | 2.81 Billion USD | -482.323% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -1648.11% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -1918.842% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -5799.862% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -39183.13% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -2353.886% |
| Nkarta, Inc. | 378.88 Million USD | -4223.7% |
| BioCardia, Inc. | 2.98 Million USD | -548338.266% |
| Iterum Therapeutics plc | 26.25 Million USD | -62285.662% |